Alamar Biosciences
ALMR
26.48
-2.20
-7.67%
Alamar Biosciences
US · ALMR
#2657 by market cap
Listed 2026
26.48
-2.20
-7.67%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM)TipRanks · 2026/8/11
-
Rating change
Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)TipRanks · 2026/6/9
-
Rating change
Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX) and Alamar Biosciences, Inc. (ALMR)TipRanks · 2026/5/12
-
Rating change
Leerink Partners Initiates Alamar Biosciences(ALMR.US) With Buy Rating, Announces Target Price $35Market Newswire · 2026/5/13
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.97 Million in Common StockMarket Newswire · 2026/10/30
-
Rating change
A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35Market Newswire · 2026/5/12
-
Rating change
J.P. Morgan Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/7/22
-
Rating change
Stifel Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/8/11
-
Rating change
J.P. Morgan Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2026/8/11
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.68 Million in Common StockMarket Newswire · 2026/11/4
-
Rating change
Stifel Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Maintains Target Price $28Market Newswire · 2026/6/9
-
TD Cowen Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/11/4
-
BofA Securities Maintains Alamar Biosciences(ALMR.US) With Hold RatingMarket Newswire · 2026/11/5
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$3.33 Million in Common StockMarket Newswire · 2026/11/6
-
Rating change
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and ServiceTitan, Inc. Class A (TTAN)TipRanks · 2026/8/11
-
Rating change
BofA Securities Maintains Alamar Biosciences(ALMR.US) With Hold Rating, Raises Target Price to $31Market Newswire · 2026/8/11
-
Rating change
TD Cowen Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $34Market Newswire · 2026/7/15
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$8.57 Million in Common StockMarket Newswire · 2026/10/28
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$4.82 Million in Common StockMarket Newswire · 2026/10/20
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.95 Million in Common StockMarket Newswire · 2026/10/22
-
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$10.25 Million in Common StockMarket Newswire · 2026/10/24
-
Form 144 | Alamar Biosciences(ALMR.US) Insider Proposes to Sell 8.56 Million in Common StocksMarket Newswire · 2026/10/15
-
Form 144 | Alamar Biosciences(ALMR.US) Insider Proposes to Sell 10.24 Million in Common StocksMarket Newswire · 2026/10/15
-
Form 144 | Alamar Biosciences(ALMR.US) Insider Proposes to Sell 36.66 Million in Common StocksMarket Newswire · 2026/10/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Alamar Biosciences discussion 0 comments